Jack in the Box re-elects board, but chair will retire

Shareholders approved a poison pill and re-elected the board, including David Goebel, despite a challenge from activist investor Sardar Biglari.
Opinion

Biglari Capital Calls for Immediate Resignation of Jack in the Box Chairman David Goebel, Who Was Overwhelmingly Rejected by Stockholders with "Skin in the Game"

Biglari Capital Corp. ("Biglari Capital"), the largest stockholder of Jack in the Box Inc. (NasdaqGS: JACK), with a 9.86% ownership stake, today issued the following statement regarding the ...
Restaurant Dive

Jack in the Box’s board battle is getting serious

With proxy advisors saying investors have “persuasive cause” to oppose the re-election of board chair David Goebel, Sardar ...
Restaurant Dive

What’s at stake in Jack in the Box’s board battle with Biglari?

If the activist investor prevents David Goebel’s re-election as chair, the board could still reappoint him, likely starting a long and expensive board battle.
Morningstar

Biglari Capital Calls for Immediate Resignation of Jack in the Box Chairman David Goebel, Who Was Overwhelmingly Rejected by Stockholders with "Skin in the Game"

Preliminary voting results from JACK's stockholder meeting reveal a stark and troubling divide. Active fund managers and retail stockholders — those who bear the real consequences of failed corporate ...